암치료 시설 시장 규모, 점유율, 동향 분석 보고서 : 치료별, 암 유형별, 프로바이더별, 지역별, 부문별 예측(2024-2030년)

Cancer Treatment Facilities Market Size, Share, & Trends Analysis Report By Treatment (Cancer Surgery, Chemotherapy), By Cancer Type (Blood Cancer, Breast Cancer), By Provider, By Region, And Segment Forecasts, 2024 - 2030

US $ 5,950 ￦ 8,275,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,666,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,447,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

암치료 시설 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 리포트에 따르면 세계의 암치료 시설 시장 규모는 2030년까지 787억 1,000만 달러에 달할 것으로 예측되며, 예측 기간 중 CAGR은 7.75%로 성장할 것으로 예측됩니다.

시장 성장의 주요 촉진요인으로는 환자 지원 프로그램 증가, 암 인식 제고를 위한 정부의 구상, 맞춤형 의료에 대한 수요 증가 등을 들 수 있습니다.

유방암은 전 세계 여성들 사이에서 유방암과 같은 신생물 유병률이 증가함에 따라 의료 서비스 프로바이더들에게 중요한 전문 분야이자 투자 대상입니다. 첨단 진단 기술, 맞춤형 의료 및 맞춤형 치료 접근법에 대한 수요는 환자 결과와 생존율을 향상시켜 예측 기간 중 이 분야의 성장을 촉진할 것으로 예상됩니다. 예를 들어 2024년 1월 MG모바일 헬스(mHealth)케어는 양성 덩어리 및 낭종에서 종양 및 재건술에 이르기까지 모든 유형의 유방 건강 문제에 대한 종합적인 고급 치료로 환자를 지원하고 지원하는 클리닉 B를 개소했습니다.

또한 면역치료는 최근 몇년사이 일부 암 치료에 있으며, 중요한 위치를 차지하고 있습니다. 면역요법은 암에 특화된 표적에 면역체계를 집중시킴으로써 암과 싸우는 면역체계의 능력을 향상시킬 수 있으므로 존재감을 높이고 있는 첨단 치료법입니다. 이에 따라 서비스 프로바이더들은 시장에서의 입지를 강화하기 위한 전략적 구상을 강화하고 있으며, 이는 향후 수년간 성장의 원동력이 될 것으로 예상됩니다.2023년 1월, BioNTech SE는 영국 정부와 협력하여 2030년 말까지 최대 10,000명의 환자에게 변형 mRNA 면역치료제 임상시험을 제공할 예정입니다. 또한 감염성 질환 백신을 제공하고 영국 시장에서의 발자국을 늘리기 위한 투자에도 집중하고 있습니다.

또한 일부 업계 기업은 보급률을 높이기 위해 새로운 서비스를 시작하고 있습니다. 예를 들어 2024년 3월 탬파 종합병원은 탬파 메인 캠퍼스에서 TGH Cancer Institute Phase I Cancer Research Unit을 시작했습니다. 이 Phase I Cancer Research Unit의 목적은 암 환자에게 사려 깊고 종합적인 치료와 통합된 최첨단 연구 연구에 대한 액세스를 제공하는 것입니다.

암치료 시설 시장 보고서 하이라이트 :

• 치료 분야에서는 암 수술 부문이 2023년 34.12%의 매출 점유율로 시장을 장악했습니다. 로봇 수술 기술의 개발 및 채택 증가가 이 분야의 성장에 큰 영향을 미치고 있습니다. 그러나 예측 기간 중 화학요법 서비스가 가장 빠르게 성장하고 있습니다.
• 암 유형별로는 혈액암 부문이 2023년 가장 큰 매출 점유율을 차지했습니다. 이러한 성장은 전 세계에서 혈액암 치료 연구 및 개발에 대한 주요 기업의 참여가 증가하고 있기 때문입니다.
• 프로바이더 기준으로 병원 부문은 종양학 분야의 고급 진단 및 치료 능력으로 인해 2023년 가장 큰 매출 점유율을 차지했습니다.
• 아시아태평양은 암 발병률 증가, 맞춤형 의료에 대한 수요 증가, 의료 인프라 구축 증가 등의 요인으로 인해 2023년 시장을 장악했습니다.
• 2024년 5월, HCG(Healthcare, World, Enterprise)는 북 벵갈루루에 새로운 암 치료 센터를 개설하여 총 125개의 병상을 추가했습니다. 전략적으로 배치된 이 시설은 진단부터 맞춤 치료 계획까지 첨단 암 치료의 전 과정을 제공합니다.

목차

제1장 조사 방법과 범위

제2장 개요

제3장 시장 변수, 동향, 범위

• 시장 계통 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 비즈니스 환경 분석
  • Porter's Five Forces 분석
  • PESTLE 분석

제4장 암치료 시설 시장 : 치료별 추정·동향 분석

• 치료별 시장 점유율, 2023년과 2030년
• 치료별 부문 대시보드
• 치료별 시장 규모와 예측 및 동향 분석, 2018-2030년
• 골수 이식
• 화학요법
• 방사선 치료
• 호르몬 요법
• 면역치료
• 암수술

제5장 암치료 시설 시장 : 암 유형별 추정·동향 분석

• 암 유형별 시장 점유율, 2023년 및 2030년
• 암 유형별 부문 대시보드
• 암 유형별 시장 규모와 예측 및 동향 분석, 2018-2030년
• 혈액암
• 유방암
• 전립선암
• 소화기암
• 부인과 암
• 호흡기/폐암
• 기타 암 유형

제6장 암치료 시설 시장 : 프로바이더별 추정·동향 분석

• 프로바이더별 시장 점유율, 2023년 및 2030년
• 프로바이더별 부문 대시보드
• 프로바이더별 시장 규모와 예측 및 동향 분석, 2018-2030년
• 암센터
• 병원

제7장 암치료 시설 시장 : 지역별 추정·동향 분석

• 지역별 시장 점유율 분석, 2023년 및 2030년
• 지역 시장 대시보드
• 시장 규모와 예측 동향 분석, 2018-2030년
• 북미
  • 북미의 암치료 시설 시장 추산·예측, 2018-2030년
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 유럽의 암치료 시설 시장 추산·예측, 2018-2030년
  • 독일
  • 영국
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 아시아태평양의 암치료 시설 시장 추산·예측, 2018-2030년
  • 일본
  • 중국
  • 인도
  • 한국
  • 호주
  • 태국
• 라틴아메리카
  • 라틴아메리카의 암치료 시설 시장 추산·예측, 2018-2030년
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 중동 및 아프리카 암치료 시설 시장 추산·예측, 2018-2030
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제8장 경쟁 구도

• 참가자 개요
• 기업의 시장 현황 분석
• 기업 분류
• 전략 지도제작
• 기업 개요/리스트
  • Compass Oncology
  • American Oncology Institute
  • Mayo Foundation for Medical Education and Research(MFMER)
  • HCA International Limited
  • The Royal Marsden
  • National Cancer Instituteat the National Institutes of Health
  • Apollo Hospitals Enterprise Ltd.
  • Kokilaben Dhirubhai Ambani Hospital
  • HEALTHCARE GLOBAL ENTERPRISES LIMITED
  • The Johns Hopkins Hospital
  • Tata Memorial Centre.

KSA

영문 목차

영문목차

Cancer Treatment Facilities Market Growth & Trends:

The global cancer treatment facilities market size is anticipated to reach USD 78.71 billion by 2030 and is anticipated to grow at a CAGR of 7.75% over the forecast period, according to a new report by Grand View Research, Inc. Key drivers of market growth include increasing patient assistance programs, government initiatives for cancer awareness, and the increasing demand for personalized medicine.

The increasing prevalence of neoplasm, such as breast cancer, among women worldwide makes it a significant area of specialization and investment for healthcare providers. The demand for advanced diagnostic technologies, personalized medicine, and tailored treatment approaches enhances patient outcomes and survival rates and is expected to drive the growth of the segment during the forecast period. For instance, in January 2024, MGM Healthcare launched Clinic B to support and help patients with comprehensive and advanced treatment for all types of breast health problems - ranging from benign lumps and cysts to tumors and reconstruction.

Furthermore, immunotherapy has become an important part of treating some types of cancer in recent years. Immunotherapy is an advanced type of treatment that is growing its presence due to its ability to enhance the immune system's ability to fight cancer by directing it toward cancer-specific targets; this leads to growing strategic initiatives by the service providers to grow its presence in the market, which is expected to drive the growth in the coming years. In January 2023, BioNTech SE collaborated with the UK government to provide clinical trials for modified mRNA immunotherapies for up to 10,000 patients by the end of 2030. In addition, it is focused on offering infectious disease vaccines and investment to increase its footprint in the UK market.

Furthermore, several industry players are launching new services to improve their penetration. For instance, in March 2024, Tampa General Hospital commenced the TGH Cancer Institute Phase I Cancer Research Unit at the main campus in Tampa. The aim of this Phase I Cancer Research Unit is to provide cancer patients with access to leading-edge research studies integrated with compassionate and comprehensive care.

Cancer Treatment Facilities Market Report Highlights:

• In terms of treatment, the cancer surgery segment dominated the market with a revenue share of 34.12% in 2023. The development and increasing adoption of robotic surgery techniques is having a significant impact on the growth of the segment. However, chemotherapy services are the fastest-growing segment during the forecast period.
• Based on the cancer type, the blood cancer segment accounted for the maximum revenue share in 2023. This growth is attributed to the increasing involvement of key companies in the R&D of blood cancer treatments globally.
• Based on provider, the hospital segment accounted for the maximum revenue share in 2023 due to its advanced diagnostic and treatment capabilities in oncology departments.
• Asia Pacific dominated the market in 2023 due to factors such as the growing cancer incidence, increasing demand for personalized care, and the rise in the development of healthcare infrastructure.
• In May 2024, HCG (Healthcare Global Enterprises) opened new cancer care centers in North Bengaluru, adding a total of 125 beds. These strategically positioned facilities will provide a complete range of advanced cancer treatments, from diagnosis to personalized treatment plans.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Treatment
  • 1.2.2. Cancer Type
  • 1.2.3. Provider
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Volume Price Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing incidence of cancers
    • 3.2.1.2. Technology advancement
    • 3.2.1.3. Rising medical tourism
    • 3.2.1.4. Growing government investment in cancer treatment facility
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High initial investment cost to setup cancer treatment facility
    • 3.2.2.2. Stringent regulations for cancer treatment facility setup
• 3.3. Business Environment Analysis
  • 3.3.1. Porter's Five Forces Analysis
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. Cancer Treatment Facilities Market: Treatment Estimates & Trend Analysis

• 4.1. Treatment Market Share, 2023 & 2030
• 4.2. Treatment Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Treatment, 2018 to 2030 (USD Million)
• 4.4. Bone Marrow Transplantation
  • 4.4.1. Bone marrow transplantation market estimates and forecasts, 2018 - 2030 (USD Million)
• 4.5. Chemotherapy
  • 4.5.1. Chemotherapy market estimates and forecasts, 2018 - 2030 (USD Million)
• 4.6. Radiation Therapy
  • 4.6.1. Radiation therapy market estimates and forecasts, 2018 - 2030 (USD Million)
• 4.7. Hormone Therapy
  • 4.7.1. Hormone therapy market estimates and forecasts, 2018 - 2030 (USD Million)
• 4.8. Immunotherapy
  • 4.8.1. Immunotherapy market estimates and forecasts, 2018 - 2030 (USD Million)
• 4.9. Cancer Surgery
  • 4.9.1. Cancer surgery market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. Cancer Treatment Facilities Market: Cancer Type Estimates & Trend Analysis

• 5.1. Cancer Type Market Share, 2023 & 2030
• 5.2. Cancer Type Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analyses, by Cancer type, 2018 to 2030 (USD Million)
• 5.4. Blood Cancer
  • 5.4.1. Blood cancer market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.5. Breast Cancer
  • 5.5.1. Breast cancer market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.6. Prostate Cancer
  • 5.6.1. Prostate cancer market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.7. Gastrointestinal Cancer
  • 5.7.1. Gastrointestinal cancer market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.8. Gynecologic Cancer
  • 5.8.1. Gynecologic cancer market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.9. Respiratory/Lung Cancer
  • 5.9.1. Respiratory/Lung cancer market estimates and forecasts, 2018 - 2030 (USD Million)
• 5.10. Other Cancer Types
  • 5.10.1. Other cancer types market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Cancer Treatment Facilities Market: Provider Estimates & Trend Analysis

• 6.1. Provider Market Share, 2023 & 2030
• 6.2. Provider Segment Dashboard
• 6.3. Market Size & Forecasts and Trend Analyses, by Provider, 2018 to 2030 (USD Million)
• 6.4. Cancer Centers
  • 6.4.1. Cancer centers market estimates and forecasts, 2018 - 2030 (USD Million)
• 6.5. Hospitals
  • 6.5.1. Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Cancer Treatment Facilities Market: Regional Estimates & Trend Analysis

• 7.1. Regional Market Share Analysis, 2023 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030
• 7.4. North America
  • 7.4.1. North America cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.2. U.S.
    • 7.4.2.1. Key country dynamic
    • 7.4.2.2. Regulatory framework
    • 7.4.2.3. Competitive insights
    • 7.4.2.4. U.S. cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. Canada
    • 7.4.3.1. Key country dynamic
    • 7.4.3.2. Regulatory framework
    • 7.4.3.3. Competitive insights
    • 7.4.3.4. Canada cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. Mexico
    • 7.4.4.1. Key country dynamic
    • 7.4.4.2. Regulatory framework
    • 7.4.4.3. Competitive insights
    • 7.4.4.4. Mexico cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.5. Europe
  • 7.5.1. Europe cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. Germany
    • 7.5.2.1. Key country dynamic
    • 7.5.2.2. Regulatory framework
    • 7.5.2.3. Competitive insights
    • 7.5.2.4. Germany cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. UK
    • 7.5.3.1. Key country dynamic
    • 7.5.3.2. Regulatory framework
    • 7.5.3.3. Competitive insights
    • 7.5.3.4. UK cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. France
    • 7.5.4.1. Key country dynamic
    • 7.5.4.2. Regulatory framework
    • 7.5.4.3. Competitive insights
    • 7.5.4.4. France cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. Italy
    • 7.5.5.1. Key country dynamic
    • 7.5.5.2. Regulatory framework
    • 7.5.5.3. Competitive insights
    • 7.5.5.4. Italy cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.6. Spain
    • 7.5.6.1. Key country dynamic
    • 7.5.6.2. Regulatory framework
    • 7.5.6.3. Competitive insights
    • 7.5.6.4. Spain cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. Denmark
    • 7.5.7.1. Key country dynamic
    • 7.5.7.2. Regulatory framework
    • 7.5.7.3. Competitive insights
    • 7.5.7.4. Denmark cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.8. Sweden
    • 7.5.8.1. Key country dynamic
    • 7.5.8.2. Regulatory framework
    • 7.5.8.3. Competitive insights
    • 7.5.8.4. Sweden cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.9. Norway
    • 7.5.9.1. Key country dynamic
    • 7.5.9.2. Regulatory framework
    • 7.5.9.3. Competitive insights
    • 7.5.9.4. Norway cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.6. Asia Pacific
  • 7.6.1. Asia Pacific cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. Japan
    • 7.6.2.1. Key country dynamic
    • 7.6.2.2. Regulatory framework
    • 7.6.2.3. Competitive insights
    • 7.6.2.4. Japan cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. China
    • 7.6.3.1. Key country dynamic
    • 7.6.3.2. Regulatory framework
    • 7.6.3.3. Competitive insights
    • 7.6.3.4. China cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. India
    • 7.6.4.1. Key country dynamic
    • 7.6.4.2. Regulatory framework
    • 7.6.4.3. Competitive insights
    • 7.6.4.4. India cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. South Korea
    • 7.6.5.1. Key country dynamic
    • 7.6.5.2. Regulatory framework
    • 7.6.5.3. Competitive insights
    • 7.6.5.4. South Korea cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. Australia
    • 7.6.6.1. Key country dynamic
    • 7.6.6.2. Regulatory framework
    • 7.6.6.3. Competitive insights
    • 7.6.6.4. Australia cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.7. Thailand
    • 7.6.7.1. Key country dynamic
    • 7.6.7.2. Regulatory framework
    • 7.6.7.3. Competitive insights
    • 7.6.7.4. Thailand cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.7. Latin America
  • 7.7.1. Latin America cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. Brazil
    • 7.7.2.1. Key country dynamic
    • 7.7.2.2. Regulatory framework
    • 7.7.2.3. Competitive insights
    • 7.7.2.4. Brazil cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. Argentina
    • 7.7.3.1. Key country dynamic
    • 7.7.3.2. Regulatory framework
    • 7.7.3.3. Competitive insights
    • 7.7.3.4. Argentina cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.8. MEA
  • 7.8.1. MEA cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.8.2. South Africa
    • 7.8.2.1. Key country dynamic
    • 7.8.2.2. Regulatory framework
    • 7.8.2.3. Competitive insights
    • 7.8.2.4. South Africa cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Saudi Arabia
    • 7.8.3.1. Key country dynamic
    • 7.8.3.2. Regulatory framework
    • 7.8.3.3. Competitive insights
    • 7.8.3.4. Saudi Arabia cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.8.4. UAE
    • 7.8.4.1. Key country dynamic
    • 7.8.4.2. Regulatory framework
    • 7.8.4.3. Competitive insights
    • 7.8.4.4. UAE cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.8.5. Kuwait
    • 7.8.5.1. Key country dynamic
    • 7.8.5.2. Regulatory framework
    • 7.8.5.3. Competitive insights
    • 7.8.5.4. Kuwait cancer treatment facilities market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Participant Overview
• 8.2. Company Market Position Analysis
• 8.3. Company Categorization
• 8.4. Strategy Mapping
• 8.5. Company Profiles/Listing
  • 8.5.1. Compass Oncology
    • 8.5.1.1. Overview
    • 8.5.1.2. Financial performance
    • 8.5.1.3. Service benchmarking
    • 8.5.1.4. Strategic initiatives
  • 8.5.2. American Oncology Institute
    • 8.5.2.1. Overview
    • 8.5.2.2. Financial performance
    • 8.5.2.3. Service benchmarking
    • 8.5.2.4. Strategic initiatives
  • 8.5.3. Mayo Foundation for Medical Education and Research (MFMER)
    • 8.5.3.1. Overview
    • 8.5.3.2. Financial performance
    • 8.5.3.3. Service benchmarking
    • 8.5.3.4. Strategic initiatives
  • 8.5.4. HCA International Limited
    • 8.5.4.1. Overview
    • 8.5.4.2. Financial performance
    • 8.5.4.3. Service benchmarking
    • 8.5.4.4. Strategic initiatives
  • 8.5.5. The Royal Marsden
    • 8.5.5.1. Overview
    • 8.5.5.2. Financial performance
    • 8.5.5.3. Service benchmarking
    • 8.5.5.4. Strategic initiatives
  • 8.5.6. National Cancer Instituteat the National Institutes of Health
    • 8.5.6.1. Overview
    • 8.5.6.2. Financial performance
    • 8.5.6.3. Service benchmarking
    • 8.5.6.4. Strategic initiatives
  • 8.5.7. Apollo Hospitals Enterprise Ltd.
    • 8.5.7.1. Overview
    • 8.5.7.2. Financial performance
    • 8.5.7.3. Service benchmarking
    • 8.5.7.4. Strategic initiatives
  • 8.5.8. Kokilaben Dhirubhai Ambani Hospital
    • 8.5.8.1. Overview
    • 8.5.8.2. Financial performance
    • 8.5.8.3. Service benchmarking
    • 8.5.8.4. Strategic initiatives
  • 8.5.9. HEALTHCARE GLOBAL ENTERPRISES LIMITED
    • 8.5.9.1. Overview
    • 8.5.9.2. Financial performance
    • 8.5.9.3. Service benchmarking
    • 8.5.9.4. Strategic initiatives
  • 8.5.10. The Johns Hopkins Hospital
    • 8.5.10.1. Overview
    • 8.5.10.2. Financial performance
    • 8.5.10.3. Service benchmarking
    • 8.5.10.4. Strategic initiatives
  • 8.5.11. Tata Memorial Centre.
    • 8.5.11.1. Overview
    • 8.5.11.2. Financial performance
    • 8.5.11.3. Service benchmarking
    • 8.5.11.4. Strategic initiatives

관련자료